Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Angiodynamics (ANGO) Gross Profit (2016 - 2025)

Historic Gross Profit for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $44.8 million.

  • Angiodynamics' Gross Profit rose 1222.12% to $44.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $167.7 million, marking a year-over-year increase of 1106.51%. This contributed to the annual value of $157.7 million for FY2025, which is 194.38% up from last year.
  • According to the latest figures from Q4 2025, Angiodynamics' Gross Profit is $44.8 million, which was up 1222.12% from $41.9 million recorded in Q3 2025.
  • Angiodynamics' 5-year Gross Profit high stood at $46.5 million for Q2 2022, and its period low was $35.9 million during Q1 2024.
  • Its 5-year average for Gross Profit is $41.0 million, with a median of $40.4 million in 2023.
  • Its Gross Profit has fluctuated over the past 5 years, first skyrocketed by 4007.68% in 2021, then plummeted by 1692.01% in 2024.
  • Angiodynamics' Gross Profit (Quarter) stood at $40.6 million in 2021, then rose by 11.15% to $45.1 million in 2022, then fell by 10.68% to $40.3 million in 2023, then fell by 0.88% to $39.9 million in 2024, then rose by 12.22% to $44.8 million in 2025.
  • Its Gross Profit was $44.8 million in Q4 2025, compared to $41.9 million in Q3 2025 and $42.2 million in Q2 2025.